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calibrator ranged from 3.6 - 17.3% (2016- 2018). The corresponding CVs 
for FIX were 2.9 - 26.2% (2013- 2015) and from 5.5 - 17.8% (2016- 2018). 
 Conclusions :  Laboratory performance of FVIII and FIX testing has 
improved over the past six years. Assessments based against calibra-
tor rather than reagent showed reduction in the numbers of outliers 
in each peer group and provided improved comparability of results 
with reduced CVs. The decreasing trend in outliers also supports the 
retention of the assessment criteria being based on calibrator. 
 PB0140  |  Are Global Coagulation Assays Better 
Measures of the Intensity of Anticoagulation in 
Patients with Antiphospholipid Syndrome? 
 W.H.  Wong 1  ;  M.C.  Kong 2  ;  E.J.S.  See 2  ;  S.H.  Yeang 2  ;  S.K. 
 Koh 3  ;  Y.T.  Shim 2  ;  C.W.  Tan 1  ;  H.J.  Ng 1  
 1 Singapore General Hospital, Haematology, Singapore, Singapore,  2 Singapore 
General Hospital, Pharmacy, Singapore, Singapore,  3 Singapore General Hospital, 
Singapore, Singapore 
 Background :  Antiphospholipid antibodies may interfere with the 
prothrombin time and higher international normalized ratio (INR) 
targets have been proposed for warfarinized antiphospholipid syn-
drome (APS) patients for perceived higher thrombogenicity. 
 Aims :  To investigate if prothrombin time- based clot wave analysis 
(PT- CWA) and platelet- poor plasma calibrated automated throm-
bogram (CAT) thrombin generation, provide better measures of the 
intensity of anticoagulation in APS patients by comparing them to 
non- APS warfarinized patients. 
 Methods :  Plasma samples from warfarinized APS patients were 
analysed for INR and PT- CWA using the Sysmex CS2100i analyzer, 
with remaining plasma used for thrombin generation analysis with 
the calibrated automated thrombogram (CAT) system. Similar pa-
rameters from warfarinized atrial fibrillation (AF) and deep vein 
thrombosis (DVT) patients were compared. Correlation to INR was 
performed using Pearson ' s correlation. Parameter means were com-
pared using multivariate analysis with correction for the age and INR 
values at 5% significance. 
 Results :  15 APS plasma samples were compared to 28 and 59 sam-
ples from AF and DVT patients. Increasing INR did not correspond-
ingly increased PT- CWA parameters in the APS and DVT group and 
minimally in the AF group. Despite similar INR range samples in the 
APS and AF groups, the ETP for the APS group (379.19 ± 79.90) was 
lower than the AF (455.14 ± 57.25) group after age and INR correc-
tions. The PT- CWA did not significantly differ amongst the various 
groups, was not affected by the INR with no significant differences 
between the groups for samples within the therapeutic range. 
 Conclusions :  PT- CWA parameters do not provide a different meas-
ure of anticoagulation intensity in APS patients who display lower 
thrombin generation potential compare to similar warfarinized AF 
and DVT patients. The role of such global assays remain unsubstanti-
ated in the management of APS. 
 
 PB0141  |  A Rapid, Practical and Ergonomic 
Device to Prepare Plasma Sample Free of 
Platelets and Direct Oral Anticoagulant for 
Routine Hemostasis Tests 
 D.  Gheldof 1  ;  A.-S.  Delvigne 1  ;  C.  Bouvy 2  ;  J.  Douxfils 1,2  ;  J.-M. 
 Dogné 1  
 1 University of Namur, Namur, Belgium,  2 Qualiblood s.a., Namur, Belgium 
TA B L E  1 TG and PT-CWA correlations to INR 
 Group  INR range 
 Correlations to INR 
 ETP  PTMin1  PTMin2  PTMax2 
 AF (n=28)  1.94 - 6.29  - 0.261  - 0.376  0.326  0.042 
 APS (n=15)  1.81 - 7.38  0.128  0.061  0.053  - 0.010 
 DVT (n=59)  1.55 - 5.38  - 0.350  0.043  0.018  - 0.087 
TA B L E  2   Means of various parameters obtained from all samples in the groups and within therapeutic range, after adjustment for age 
and INR 
 INR range  Group 
 Adjusted means ± SE 
 ETP  PTMin2  PTMin2  PTMax2 
 All  AF  455.14 ± 57.25  3.03 ± 0.22  0.786 ± 0.06  0.575 ± 0.04 
  APS  379.19 ± 79.90  3.31 ± 0.31  0.842 ± 0.08  0.578 ± 0.05 
  DVT  440.24 ± 38.22  3.04 ± 0.15  0.790 ± 0.04  0.577 ± 0.03 
 Therapeutic range (2.0 
- 3.5) 
 AF  517.16 ± 100.15  2.86 ± 0.37  0.757 ± 0.10  0.599 ± 0.07 
  APS  262.79 ± 116.86  3.15 ± 0.44  0.795 ± 0.11  0.524 ± 0.08 
  DVT  517.15 ± 58.73  2.90 ± 0.22  0.766 ± 0.06  0.597 ± 0.04 
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 Background :  Direct oral anticoagulants (DOACs) are known to inter-
fere with almost all clotting tests to varying degrees. This may lead 
to false positive or false negative tests results and to unnecessary 
investigations. 
 Aims :  To assess the effectiveness of the one step plasma prepara-
tion by filtration with the original DOAC & Platelets Filter (DP- Filter) 
device from the University of Namur on i) the removal of platelets 
from plasma in substitution of the second centrifugation and ii) the 
removal of all types of DOAC including dabigatran, apixaban, rivar-
oxaban and edoxaban from test plasma (with minimal effect on he-
mostasis variable). 
 Methods :  i) Platelet- poor plasma was prepared in two different ways: 
i) by a double centrifugation at 2500g during 15 min or by a single 
centrifugation at 2500g during 15 min followed by one filtration 
by centrifugation at 200g during 2 min with the DP- Filter. Platelets 
count was assessed using a Sysmex XN- 9000 analyzer. ii) Normal 
pooled plasma were mixed with either dabigatran, apixaban, rivar-
oxaban and edoxaban at 0- 100- 300- 1000 ng/ml. Plasma DOAC con-
centrations were assessed before and after filtration with DP- Filter 
using calibrated STA- Liquid anti- Xa or STA- ECAII for anti- Xa and 
anti- IIa drugs, respectively. Prothrombin time (PT) and activated par-
tial thromboplastin time (aPTT) were also assessed before and after 
filtration to assess the impact of DP- Filter on hemostasis parameters. 
 Results :  DP- Filter efficiently removed platelets and DOACs to concen-
trations until 1000 ng/mL to levels below the limits of detection of the 
instrument/tests. DP- Filter was able to restore normal prothrombin time 
and activated partial thromboplastin time at all DOACs concentrations. 
 Conclusions :  DP- Filter can be used to efficiently substitute the sec-
ond centrifugation step for platelet poor plasma preparation and 
efficiently remove dabigatran, apixaban rivaroxaban and edoxaban 
from plasma to concentrations up to 1000 ng/ml. Global hemostasis 
parameters were restored and are not influenced by the device. 
 PB0142  |  Pronounced Alterations of Thrombin 
Generation Profiles are Found in Whole Blood 
Compared to Plasma of Liver Disease Patients 
 J.  Wan 1,2  ;  W.  Hendrix 1  ;  T.-W.  Ow 3  ;  R.  Arya 4  ;  L.  Rabinowich 3  ; 
 O.  Barbouti 3  ;  J.  Konings 1,2  ;  B.  de Laat 1,2  ;  T.  Lisman 5  ;  L. 
 Roberts 4  ;  W.  Bernal 3  ;  M.  Roest 1,2  
 1 Synapse Research Institute, Maastricht, the Netherlands,  2 Maastricht 
University, Cardiovascular Research Institute, Maastricht, the Netherlands, 
 3 King ' s College Hospital NHS Foundation Trust, Institute of Liver Studies, 
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King ' s Thrombosis Centre, Department of Haematological Medicine, London, 
United Kingdom,  5 University Medical Center Groningen, Department of Surgery, 
Groningen, the Netherlands 
 Background :  Severe distortions of both pro- and anticoagulant driv-
ers in liver disease patients result in a ‘frailly rebalanced’ haemostatic 
system. Novel global coagulation tests like thrombin generation 
(TG) assess the integration of the pro- and anticoagulant system. 
Function of the blood cells may cause additional influence on the 
global coagulation. 
 Aims :  To study the whole blood (WB) and plasma TG profiles of liver 
disease patients. 
 Methods :  Liver disease patients under medium care (MC; n=30), in-
tensive care (IC, n=6) and controls were recruited at King ' s College 
Hospital, London. The study was approved by the local ethic com-
mittee and all participants gave consent for the study. TG in Citrated 
WB samples was measured with a miniaturized device at 2.5 pM tis-
sue factor (TF). TG in Platelet poor plasma (PPP) was measured at 5 
pM TF, with or without 10 nM thrombomodulin (TM). 
 Results :  MC and IC patients had significantly prolonged APTT and 
INR, lower FII, FX and antithrombin, but higher FVIII compared to 
controls. Most patients had lower platelet count and hematocrit than 
local reference range (Figure 1). In PPP- TG, only IC patients showed 
significantly lower peak and longer lagtime than controls, while with 
WB- TG this was found in both MC and IC patients. Plasma endog-
enous thrombin potential (ETP) of patients was comparable or higher 
than controls when TM was present. ETP until peak (ETPp) in WB- TG 
was similar between patients and controls (Figure 1). TG parameters 
in WB and PPP showed significant correlation (Figure 2). Significant 
F I G U R E  2   Correlations between thrombin generation 
parameters in whole blood and in plasma 
F I G U R E  1 Thrombin generation parameters and cell counts of 
liver disease patients
